The Swedish Cervical Screening Cohort

The Cervical Screening Cohort enrols women screened for human papillomavirus (HPV) and cervical abnormalities within the capital region of Sweden from the organised screening program and the non-organised testing of cervical samples. The cohort started in 2011 and has enrolled more than 670,000 wome...

Full description

Saved in:
Bibliographic Details
Published inScientific data Vol. 11; no. 1; pp. 697 - 7
Main Authors Dillner, Joakim, Mühr, Laila Sara Arroyo, Kleppe, Sara Nordqvist, Wang, Jiangrong, Andersson, Helena, Elfström, Miriam, Merino, Roxana, Sundström, Karin
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 26.06.2024
Nature Publishing Group UK
Nature Portfolio
Subjects
Adult
Cervix Uteri - pathology
Cervix Uteri - virology
Cohort Studies
Data Descriptor
Early Detection of Cancer
Female
Human papillomavirus
Humans
Mass Screening
Medical screening
Medicin och hälsovetenskap
Middle Aged
Papillomaviridae
Papillomavirus Infections - diagnosis
Registries
Sampling
Sweden - epidemiology
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - epidemiology
Sweden
Online AccessGet full text

Cover

More Information
Summary:The Cervical Screening Cohort enrols women screened for human papillomavirus (HPV) and cervical abnormalities within the capital region of Sweden from the organised screening program and the non-organised testing of cervical samples. The cohort started in 2011 and has enrolled more than 670,000 women, contributing with more than 1.2 million biobanked samples. The cohort is systematically updated with individual-level data from the Swedish National Cervical Screening Registry (NKCx). Key variables include birthdate, sampling date, cytological, histopathological and HPV analysis results, and invitation history. Each sampling and subsequent clinical follow-up is sequentially registered, allowing for longitudinal analyses of screening results and associated results of the clinical workup. The cohort is ideal for longitudinal, long-term follow-up studies due to its validated documentation and registry-derived information. From the data, it is possible to penetrate important human health mechanisms. The data are available as open-data and GDPR-compliant. Samples are available after getting the required permissions. Results will help researchers understand factors that increase cancer risk and other diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:2052-4463
2052-4463
DOI:10.1038/s41597-024-03519-2